CDKN2A and acute myeloid leukemia: These findings presumably delineate that, in the context of NPM1c AML, NPM1c de-SUMOylation is likely sustained via upregulation of SENP3, hence counteracting ARF-mediated NPM1c SUMOylation, to promote ribosomal biosynthesis, protein synthesis and leukemic blast survival.